Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Ponatinib D8 is a deuterium labeled Ponatinib. Ponatinib is an orally active inhibitor of multi-targeted kinase(Abl, PDGFRα, VEGFR2, FGFR1, and Src with IC50s of 0.37 nM, 1.1 nM, 1.5 nM, 2.2 nM, and 5.4 nM, respectively).
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | 35 days | $ 885.00 |
Description | Ponatinib D8 is a deuterium labeled Ponatinib. Ponatinib is an orally active inhibitor of multi-targeted kinase(Abl, PDGFRα, VEGFR2, FGFR1, and Src with IC50s of 0.37 nM, 1.1 nM, 1.5 nM, 2.2 nM, and 5.4 nM, respectively). |
Targets&IC50 | c-Kit:12.5 nM, PDGFRα:1.1 nM, FGFR1:2.2 nM, VEGFR2:1.5 nM |
Synonyms | AP24534 D8 |
Molecular Weight | 540.61 |
Formula | C29H27F3N6O |
CAS No. | 1562993-37-6 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Ponatinib-d8 1562993-37-6 Others Ponatinibd8 Ponatinib d8 Ponatinib-d-8 AP24534 D8 inhibitor inhibit